Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics, metabolism and drug-abuse potential of nabilone.

Literature DB >> 6299550

Pharmacokinetics, metabolism and drug-abuse potential of nabilone.

L Lemberger, A Rubin, R Wolen, K DeSante, H Rowe, R Forney, P Pence.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1982 PMID： 6299550 DOI： 10.1016/s0305-7372(82)80031-5

Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

Review 1. Pharmacokinetic optimisation of antiemetic therapy.

Authors: M Campbell; D N Bateman
Journal: Clin Pharmacokinet Date: 1992-08 Impact factor: 6.447

2. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Authors: Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal: Drug Alcohol Depend Date: 2011-01-11 Impact factor: 4.492

3. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.

Authors: Gillinder Bedi; Ziva D Cooper; Margaret Haney
Journal: Addict Biol Date: 2012-01-19 Impact factor: 4.280

4. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

Authors: Evan S Herrmann; Ziva D Cooper; Gillinder Bedi; Divya Ramesh; Stephanie C Reed; Sandra D Comer; Richard W Foltin; Margaret Haney
Journal: Psychopharmacology (Berl) Date: 2016-04-16 Impact factor: 4.530

5. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

Authors: Frances R Levin; John J Mariani; Martina Pavlicova; Daniel Brooks; Andrew Glass; Amy Mahony; Edward V Nunes; Adam Bisaga; Elias Dakwar; Kenneth M Carpenter; Maria A Sullivan; Jean C Choi
Journal: Drug Alcohol Depend Date: 2015-11-27 Impact factor: 4.492

Pharmacokinetics, metabolism and drug-abuse potential of nabilone.

Review 1. Pharmacokinetic optimisation of antiemetic therapy.

2. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

3. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.

4. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

5. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

6. Nabilone: an alternative antiemetic for cancer chemotherapy.

7. Effect of the synthetic cannabinoid nabilone on spermatogenesis in mice.

Review 8. Pharmacokinetics and pharmacodynamics of cannabinoids.

Review 9. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

10. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.